Article metrics

Download PDFPDF
Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus

 

Online download statistics by month:

Online download statistics by month: January 2019 to August 2022

AbstractFullPdf
Jan 201910466446
Feb 2019177511275
Mar 201911574130
Apr 2019103512592
May 20194189664
Jun 20193514332
Jul 20192345338
Aug 20191523017
Sep 2019942519
Oct 20191271922
Nov 20191292721
Dec 20191662020
Jan 20201233322
Feb 20201971713
Mar 2020821514
Apr 2020731411
May 20202252819
Jun 20201891210
Jul 202013397
Aug 20207135
Sep 20201321611
Oct 20201041511
Nov 2020109129
Dec 2020132168
Jan 20211481819
Feb 2021711617
Mar 2021971512
Apr 2021991312
May 20211102525
Jun 2021261712
Jul 202122147
Aug 2021281617
Sep 2021251711
Oct 20211193417
Nov 20211962715
Dec 20212792413
Jan 2022109104
Feb 20221702517
Mar 20221433327
Apr 2022132126
May 20223042019
Jun 20221782123
Jul 20221622313
Aug 20222232714
Total108951252916